CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection

Gastroenterology. 2010 May;138(5):1836-44. doi: 10.1053/j.gastro.2009.12.042. Epub 2010 Jan 4.

Abstract

Background & aims: The gastric epithelium genome undergoes extensive epigenetic alterations during Helicobacter pylori-induced gastritis. Expression of the gene encoding the DNA repair protein O6-methylguanine DNA methyltransferase (MGMT) might be reduced via hypermethylation of its promoter in patients with H pylori gastritis. We characterized expression of MGMT and its epigenetic regulation via CpG methylation in gastric tissue from patients with H pylori gastritis and investigated the effects of H pylori infection eradication on MGMT expression.

Methods: Gastric biopsy samples were collected from patients with H pylori gastritis before and after eradication and from H pylori-negative control subjects. AGS cells were cocultured with H pylori to study the effects of H pylori infection on MGMT RNA, protein expression, and CpG methylation.

Results: CpG methylation of MGMT was more frequent in the gastric mucosa of patients with H pylori gastritis (69.7%) than in those without (28.6%, P = .022). MGMT methylation was significantly reduced after H pylori eradication (from 70% to 48% of cases, P = .039), and mean levels of CpG methylation decreased from 12.6% to 5.7% (P = .025), increasing MGMT expression. MGMT methylation was significantly associated with CagA-positive H pylori (P = .035). H pylori reduced MGMT protein and RNA levels and induced MGMT CpG methylation in gastric AGS cells.

Conclusions: H pylori gastritis, particularly in patients infected with H pylori CagA-positive strains, is associated with hypermethylation of MGMT and reduced levels of MGMT in the gastric epithelium. MGMT promoter methylation is partially reversible after eradication of H pylori infection. These data indicate that DNA repair is disrupted during H pylori gastritis, increasing mutagenesis in H pylori-infected gastric mucosa.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Antigens, Bacterial / metabolism
  • Bacterial Proteins / metabolism
  • Biopsy
  • Case-Control Studies
  • Cell Line
  • CpG Islands*
  • DNA Methylation*
  • DNA Modification Methylases / genetics*
  • DNA Repair
  • DNA Repair Enzymes / genetics*
  • Down-Regulation
  • Epigenesis, Genetic
  • Female
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / enzymology*
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Gastritis / drug therapy
  • Gastritis / enzymology
  • Gastritis / genetics*
  • Gastritis / microbiology
  • Gene Expression Regulation, Enzymologic*
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / enzymology
  • Helicobacter Infections / genetics*
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / metabolism
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Male
  • Middle Aged
  • Mutagenesis
  • Promoter Regions, Genetic
  • RNA, Messenger / metabolism
  • Treatment Outcome
  • Tumor Suppressor Proteins / genetics*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Antigens, Bacterial
  • Bacterial Proteins
  • RNA, Messenger
  • Tumor Suppressor Proteins
  • cagA protein, Helicobacter pylori
  • DNA Modification Methylases
  • MGMT protein, human
  • DNA Repair Enzymes